ArticleAnatolian journal of cardiology2021

Bleeding risk with concomitant use of tirofiban and third-generation P2Y12 receptor antagonists in patients with acute myocardial infarction: A real-life data.

Mustafa Kürşat Tigen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.